16-81090670-G-A

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_004483.5(GCSH):​c.159C>T​(p.Phe53Phe) variant causes a synonymous change. The variant allele was found at a frequency of 0.0657 in 1,609,126 control chromosomes in the GnomAD database, including 4,042 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.057 ( 257 hom., cov: 32)
Exomes 𝑓: 0.067 ( 3785 hom. )

Consequence

GCSH
NM_004483.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.11

Publications

17 publications found
Variant links:
Genes affected
GCSH (HGNC:4208): (glycine cleavage system protein H) Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). The protein encoded by this gene is the H protein, which transfers the methylamine group of glycine from the P protein to the T protein. Defects in this gene are a cause of nonketotic hyperglycinemia (NKH). Two transcript variants, one protein-coding and the other probably not protein-coding,have been found for this gene. Also, several transcribed and non-transcribed pseudogenes of this gene exist throughout the genome.[provided by RefSeq, Jan 2010]
GCSH Gene-Disease associations (from GenCC):
  • glycine encephalopathy
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, Ambry Genetics
  • multiple mitochondrial dysfunctions syndrome 7
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • infantile glycine encephalopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • neonatal glycine encephalopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • atypical glycine encephalopathy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 16-81090670-G-A is Benign according to our data. Variant chr16-81090670-G-A is described in ClinVar as Benign. ClinVar VariationId is 1166773.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0717 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004483.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GCSH
NM_004483.5
MANE Select
c.159C>Tp.Phe53Phe
synonymous
Exon 2 of 5NP_004474.2
GCSH
NR_033249.2
n.276C>T
non_coding_transcript_exon
Exon 2 of 4

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GCSH
ENST00000315467.9
TSL:1 MANE Select
c.159C>Tp.Phe53Phe
synonymous
Exon 2 of 5ENSP00000319531.3
ENSG00000284512
ENST00000640345.1
TSL:5
c.159C>Tp.Phe53Phe
synonymous
Exon 2 of 6ENSP00000492798.1
ENSG00000260643
ENST00000564536.2
TSL:5
c.159C>Tp.Phe53Phe
synonymous
Exon 2 of 6ENSP00000491651.1

Frequencies

GnomAD3 genomes
AF:
0.0571
AC:
8686
AN:
152074
Hom.:
255
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0352
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.0482
Gnomad ASJ
AF:
0.0291
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.0247
Gnomad FIN
AF:
0.108
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0734
Gnomad OTH
AF:
0.0506
GnomAD2 exomes
AF:
0.0540
AC:
13570
AN:
251404
AF XY:
0.0541
show subpopulations
Gnomad AFR exome
AF:
0.0391
Gnomad AMR exome
AF:
0.0265
Gnomad ASJ exome
AF:
0.0300
Gnomad EAS exome
AF:
0.00114
Gnomad FIN exome
AF:
0.107
Gnomad NFE exome
AF:
0.0728
Gnomad OTH exome
AF:
0.0554
GnomAD4 exome
AF:
0.0666
AC:
96966
AN:
1456934
Hom.:
3785
Cov.:
29
AF XY:
0.0652
AC XY:
47297
AN XY:
725144
show subpopulations
African (AFR)
AF:
0.0336
AC:
1124
AN:
33414
American (AMR)
AF:
0.0286
AC:
1279
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0295
AC:
770
AN:
26110
East Asian (EAS)
AF:
0.000504
AC:
20
AN:
39682
South Asian (SAS)
AF:
0.0256
AC:
2208
AN:
86192
European-Finnish (FIN)
AF:
0.105
AC:
5619
AN:
53408
Middle Eastern (MID)
AF:
0.0391
AC:
225
AN:
5756
European-Non Finnish (NFE)
AF:
0.0742
AC:
82121
AN:
1107402
Other (OTH)
AF:
0.0598
AC:
3600
AN:
60246
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
4220
8440
12660
16880
21100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2926
5852
8778
11704
14630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0572
AC:
8698
AN:
152192
Hom.:
257
Cov.:
32
AF XY:
0.0575
AC XY:
4279
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0354
AC:
1470
AN:
41544
American (AMR)
AF:
0.0482
AC:
735
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
101
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5184
South Asian (SAS)
AF:
0.0241
AC:
116
AN:
4820
European-Finnish (FIN)
AF:
0.108
AC:
1147
AN:
10584
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0734
AC:
4991
AN:
68010
Other (OTH)
AF:
0.0520
AC:
110
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
427
854
1282
1709
2136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0656
Hom.:
491
Bravo
AF:
0.0514
Asia WGS
AF:
0.0170
AC:
60
AN:
3478
EpiCase
AF:
0.0682
EpiControl
AF:
0.0666

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glycine encephalopathy Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
13
DANN
Benign
0.86
PhyloP100
4.1
PromoterAI
0.00020
Neutral
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8177876; hg19: chr16-81124275; API